A detailed history of Lido Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Lido Advisors, LLC holds 2,000 shares of NVO stock, worth $174,740. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Previous 151,662 98.68%
Holding current value
$174,740
Previous $21.6 Million 98.9%
% of portfolio
0.0%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $2.51 Million - $3.07 Million
21,087 Added 13.9%
172,749 $20.6 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $642,509 - $769,220
5,236 Added 3.58%
151,662 $21.6 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $1.13 Million - $1.51 Million
11,076 Added 8.18%
146,426 $18.8 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $920,812 - $1.11 Million
10,490 Added 8.4%
135,350 $14 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $5.94 Million - $13 Million
65,337 Added 109.77%
124,860 $11.4 Million
Q2 2023

Aug 09, 2023

BUY
$155.98 - $172.65 $8.19 Million - $9.07 Million
52,534 Added 751.67%
59,523 $9.63 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $303,190 - $364,589
2,291 Added 48.77%
6,989 $1.11 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $83,373 - $110,023
813 Added 20.93%
4,698 $635,000
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $28,869 - $35,429
303 Added 8.46%
3,885 $387,000
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $70,925 - $83,683
687 Added 23.73%
3,582 $399,000
Q1 2022

May 17, 2022

BUY
$93.1 - $112.54 $48,132 - $58,183
517 Added 21.74%
2,895 $321,000
Q4 2021

Feb 15, 2022

BUY
$95.88 - $117.08 $228,002 - $278,416
2,378 New
2,378 $266,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.